MetaCap

Ironwood Pharmaceuticals (IRWD) vs Verastem (VSTM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Ironwood Pharmaceuticals (IRWD) has outperformed Verastem (VSTM) over the past year, gaining 48.7% versus a loss of 36.7%. Over five years, IRWD leads with a -57.9% price change compared with -80.3% for VSTM. Verastem is the larger company by market cap ($797.7 million vs $778.1 million), about 1.0 times the size.

Ironwood Pharmaceuticals converts more of its revenue into profit, with a net margin of 8.1% versus -677.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

IRWD+48.73%VSTM-36.70%
+77%+3%-72%
Nov 21, 20251 yearNov 20, 2026
IRWD-59.83%VSTM-82.18%
+37%-32%-101%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

IRWD versus VSTM key metrics
MetricIRWDVSTM
Share price$4.70$6.33
Market cap$778.09M$797.67M
1-day change-0.21%-7.73%
YTD return+39.47%-18.01%
1-year return+48.73%-36.70%
5-year return-57.89%-80.32%
P/E ratio (TTM)5.22—
Forward P/E3.00—
EPS (TTM)$0.90$-1.84
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$296.15M$30.91M
Revenue growth (YoY)-15.72%+209.14%
Net income (latest FY)$24.02M$-209.47M
Operating margin33.26%-550.33%
Net margin8.11%-677.59%
52-week high$5.78$10.82
52-week low$2.95$3.43
Distance from 52-week high-18.69%-41.50%
Analyst consensusbuystrong_buy
Avg. price target upside+31.49%+172.04%
Average volume2.15M3.53M
Shares outstanding165.55M126.01M
Employees100102
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • IRWD has outperformed VSTM by 85.4 percentage points over the past year.
  • Ironwood Pharmaceuticals is more profitable, keeping 8.1 cents of every revenue dollar as net income versus -677.6 cents for Verastem.
  • Verastem grew revenue faster in its latest fiscal year (+209.14% vs -15.72%).

About Ironwood Pharmaceuticals

IRWD stock →

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA names.

Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees

About Verastem

VSTM stock →

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK kinase activity and the compensatory reactivation of MEK by upstream RAF, thereby targeting the RAS/MAPK signaling pathway that is commonly activated in various cancers; and Defactinib, an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase for various solid tumors.

Health Care · Biotechnology: Pharmaceutical Preparations · 102 employees

IRWD vs VSTM FAQ

Which is bigger, Ironwood Pharmaceuticals or Verastem?

Verastem (VSTM) is larger, with a market capitalization of $797.67M compared with $778.09M for Ironwood Pharmaceuticals (IRWD).

Which stock has performed better over the past year, IRWD or VSTM?

IRWD returned +48.73% over the past 12 months, compared with -36.70% for VSTM (price return, excluding dividends). Past performance does not predict future results.

Are Ironwood Pharmaceuticals and Verastem in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons